Get the Stockscreener App
0.2029
1.27%
-0.0026
After Hours:
.20
-0.0029
-1.43%
Essa Pharma Inc stock is traded at $0.2029, with a volume of 1.68M.
It is down -1.27% in the last 24 hours and down -89.38% over the past month.
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
See More
Previous Close:
$0.2055
Open:
$0.211
24h Volume:
1.68M
Relative Volume:
0.32
Market Cap:
$9.60M
Revenue:
-
Net Income/Loss:
$-28.54M
P/E Ratio:
-0.317
EPS:
-0.64
Net Cash Flow:
$-22.72M
1W Performance:
-12.88%
1M Performance:
-89.38%
6M Performance:
-87.78%
1Y Performance:
-97.14%
1-Day Range:
$0.2016
$0.211
1-Week Range:
$0.1912
$0.245
52-Week Range:
$0.1912
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Name
Essa Pharma Inc
Sector
Industry
Phone
(778) 331-0962
Address
SUITE 720, VANCOUVER, BC
Compare EPIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
0.2029 | 9.70M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-04-24 | Downgrade | Jefferies | Buy → Hold |
| Nov-04-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-04-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-26-23 | Resumed | Oppenheimer | Outperform |
| Mar-04-21 | Initiated | Piper Sandler | Overweight |
| Jan-11-21 | Reiterated | H.C. Wainwright | Buy |
| Nov-02-20 | Initiated | Jefferies | Buy |
| Oct-25-19 | Initiated | Oppenheimer | Outperform |
View All
Essa Pharma Inc Stock (EPIX) Latest News
Can ESSA Pharma Inc. stock deliver consistent earnings growthEarnings Recap Report & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Is ESSA Pharma Inc. stock bottoming outTrade Performance Summary & Smart Swing Trading Techniques - Newser
How to build a custom watchlist for ESSA Pharma Inc.July 2025 Rallies & AI Powered Buy and Sell Recommendations - Newser
Will ESSA Pharma Inc. see short term momentumPrice Action & Stepwise Entry/Exit Trade Alerts - Newser
Does ESSA Pharma Inc. show high probability of reboundWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Has ESSA Pharma Inc. found a price floor2025 Stock Rankings & AI Enhanced Execution Alerts - Newser
What MACD and RSI say about ESSA Pharma Inc.Wall Street Watch & Daily Stock Trend Watchlist - Newser
Is ESSA Pharma Inc. forming a bottoming baseWeekly Investment Summary & Fast Moving Trade Plans - Newser
Can swing trading help recover from ESSA Pharma Inc. lossesJuly 2025 Summary & Precise Swing Trade Entry Alerts - Newser
Visual analytics tools that track ESSA Pharma Inc. performanceEarnings Miss & High Conviction Buy Zone Alerts - Newser
Volatility clustering patterns for ESSA Pharma Inc.Market Performance Summary & Daily Entry Point Alerts - Newser
What recovery options are there for ESSA Pharma Inc.July 2025 Analyst Calls & Free Long-Term Investment Growth Plans - Newser
Using economic indicators to assess ESSA Pharma Inc. potentialJuly 2025 WrapUp & Weekly Watchlist of Top Performers - Newser
Identifying reversal signals in ESSA Pharma Inc.Layoff News & Smart Investment Allocation Insights - Newser
Published on: 2025-09-12 00:51:00 - Newser
Applying sector rotation models to ESSA Pharma Inc.Quarterly Portfolio Summary & Low Drawdown Trading Strategies - Newser
Can a trend reversal in ESSA Pharma Inc. lead to recoveryPortfolio Return Report & High Yield Equity Trading Tips - Newser
ESSA Pharma Inc. stock volume spike explainedJuly 2025 Earnings & Daily Stock Trend Reports - Newser
Tick level data insight on ESSA Pharma Inc. volatility2025 Retail Activity & Real-Time Stock Entry Alerts - Newser
Real time pattern detection on ESSA Pharma Inc. stockRecession Risk & Weekly High Potential Alerts - Newser
Will ESSA Pharma Inc. continue its uptrend2025 Volatility Report & Verified Entry Point Signals - Newser
Why ESSA Pharma Inc. is moving todayJuly 2025 Chart Watch & Safe Entry Point Identification - Newser
ESSA Pharma Reschedules Special Meeting for Acquisition - MSN
Can ESSA Pharma Inc. hit a new high this monthWeekly Gains Summary & Smart Money Movement Alerts - Newser
EPIX 8-K: Shareholder vote adjourned on proposed XenoTherapeutics acquisition - Stock Titan
Essa Pharma Inc. to Adjourn Special Meeting to September 29, 2025 - Yahoo Finance
Chart based exit strategy for ESSA Pharma Inc.2025 Market Outlook & Fast Exit and Entry Strategy Plans - Newser
Published on: 2025-09-09 17:49:21 - Newser
How to monitor ESSA Pharma Inc. with trend dashboardsStop Loss & Safe Entry Momentum Tips - Newser
Is ESSA Pharma Inc. forming a reversal patternJuly 2025 Fed Impact & Stock Portfolio Risk Management - Newser
Order flow analysis tools used on ESSA Pharma Inc.Market Trend Report & Verified High Yield Trade Plans - Newser
Published on: 2025-09-08 16:40:27 - beatles.ru
Can ESSA Pharma Inc. stock outperform in a bear marketInsider Buying & Smart Swing Trading Alerts - beatles.ru
Does ESSA Pharma Inc. have a sustainable dividendJuly 2025 News Drivers & Free Low Drawdown Momentum Trade Ideas - beatles.ru
Is ESSA Pharma Inc. stock heavily shorted2025 Top Gainers & AI Forecasted Entry and Exit Points - beatles.ru
What’s the recovery path for long term holders of ESSA Pharma Inc. - Newser
Essa Pharma Inc Stock (EPIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):